VIDEO: Canntab Therapeutics Ltd (CNSX:PILL) Cannabis Hard Tablet Delivery Mechanism
1,144 views · Published 28 September 2018 · 7:42 · Indexed 6 November 2026
Channel: Midas Letter · 2018 · News & Politics
Canntab Therapeutics Ltd (CNSX:PILL) (OTCMKTS:TLFTF) (FRA:TBF1) CEO Jeff Renwick and CFO Richard Goldstein talk about the recent doubling of Canntab’s valuation. Canntab creates pain management products by utilizes resins to produce cannabis hard tablets for the medical market. Under current ACMPR rules, bud and oil are the only Health Canada-approved delivery methods but the pair is confident in the near future, hard tablets will also be declared an acceptable oral dose delivery mechanism. They compare hard tablets to softgels and Renwick indicates that the advantage of the hard tablet is it protects the cannabinoids from degradation. They discuss Canntab’s revenue model and Goldstein indicates the company expects to see revenue from product sales in 2019. ************************ Check out our website: https://midasletter.com ************************ SUBSCRIBE to our YouTube: http://bit.ly/MidasLetterYoutube SUBSCRIBE to our Newsletter: http://bit.ly/MidasLetterNewsletter Download Our Podcast on iTunes: http://bit.ly/MidasLetterPodcast ************************ Follow Us on Twitter: http://bit.ly/MidasLetterTwitter Like Us on Instagram: http://bit.ly/MidasLetterInsta Like Us on Facebook: http://bit.ly/MidasLetterFacebook ************************ #CannTab #Cannabis #WeedStocks
More from this channel
-
6:13
Green Relief Inc CEO Warren Bravo on Growing Cannabis Using Fish
-
6:53
Crown Mining Corp (CVE:CWM) Director on Partnerships and Permitting for California Copper Projects
-
6:42
GreenBank CEO Danny Wettreich on Investing in Ubique and Blockchain Evolution
-
0:12
Hey Welcome to MIdas Letter!
-
8:42
MedReleaf CEO Neil Closner on the Recent $100 Million Financing Deal
-
7:50
Paycase Financial CEO Joseph Weinberg on Bitcoin Technology for Overseas Transactions
-
6:54
Lexaria CEO Chris Bunka on the Latest Cannabinoid Patents With Big Potential Revenue Streams
-
6:13
NeutriSci is into Energy Tablets, THC, and Genie Bouchard!